Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted priority review for its request ...

Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Priority Cycles' Current Plus e-commuter bike delivers good range and power, plus features a low-maintenance Gates belt-drive ...

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...

The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters such as addressing a national health crisis, delivering more innovative cures ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The upgraded Priority Current Plus goes fast and goes far with little effort, especially thanks to the new throttle. It’s a ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...